Skip to content

NEXTBio Capital Management LP

Follow

13F filer, CIK 2038158, AUSTIN, TX

NEXTBio Capital Management LP reported $234,373,442 across 25 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 67.64% of the portfolio.

Accepted , ingested 13F-HR 0001172661-26-004969

Period
2026-09-30
Reported value
$234M
Holdings
25
Top 10 weight
67.64%
New
5
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ENTXnew+2,923,937$8.51M
PHVSadded+264,497$8.39M
KRSAnew+175,403$5.61M
XENEadded+127,000$4.72M
BLSMnew+250,000$4.66M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VORreduced-268,233-$5.12M
VSTMreduced-400,058-$3.22M
BIOAexited-100,732-$2.47M
ACETexited-157,827-$1.36M
PVLAreduced-9,500-$1.31M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001172661-26-004969, largest first. % of portfolio is the value over $234,373,442, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 229,619 shares; 2026Q1: 229,619 shares; 2026Q2: 219,333 shares; 2026Q3: 219,333 shares 219,333$30.9M13.18%0Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,149,907 shares; 2026Q1: 3,149,907 shares; 2026Q2: 3,727,348 shares; 2026Q3: 3,727,348 shares 3,727,348$25.4M10.85%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 752,631 shares; 2026Q1: 2,021,407 shares; 2026Q2: 1,775,759 shares; 2026Q3: 1,775,759 shares 1,775,759$22.1M9.43%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 67,586 shares; 2026Q1: 126,078 shares; 2026Q2: 131,758 shares; 2026Q3: 131,758 shares 131,758$12.5M5.35%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 999,967 shares; 2026Q1: 999,967 shares; 2026Q2: 889,164 shares; 2026Q3: 620,931 shares 620,931$11.8M5.05%-268,233Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 108,055 shares; 2026Q3: 372,552 shares 372,552$11.8M5.04%+264,497Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 183,704 shares; 2026Q1: 183,225 shares; 2026Q2: 183,225 shares; 2026Q3: 310,225 shares 310,225$11.5M4.92%+127,000Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 321,983 shares; 2026Q1: 426,736 shares; 2026Q2: 426,736 shares; 2026Q3: 426,736 shares 426,736$11.5M4.91%0Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 82,686 shares; 2026Q1: 82,686 shares; 2026Q2: 89,909 shares; 2026Q3: 80,409 shares 80,409$11.1M4.73%-9,500Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 94,443 shares; 2026Q1: 133,239 shares; 2026Q2: 312,496 shares; 2026Q3: 312,496 shares 312,496$9.77M4.17%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 615,720 shares; 2026Q1: 523,619 shares; 2026Q2: 706,124 shares; 2026Q3: 684,476 shares 684,476$9.22M3.93%-21,648Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,923,937 shares 2,923,937$8.51M3.63%newTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,307,330 shares; 2026Q1: 1,306,800 shares; 2026Q2: 1,306,800 shares; 2026Q3: 906,742 shares 906,742$7.3M3.11%-400,058Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,298,701 shares; 2026Q1: 1,333,484 shares; 2026Q2: 1,787,984 shares; 2026Q3: 1,787,984 shares 1,787,984$6.6M2.82%0Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 163,362 shares; 2026Q1: 183,362 shares; 2026Q2: 183,362 shares; 2026Q3: 238,362 shares 238,362$6.28M2.68%+55,000Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 95,485 shares; 2026Q1: 95,223 shares; 2026Q2: 107,223 shares; 2026Q3: 107,223 shares 107,223$6.1M2.6%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 95,819 shares; 2026Q1: 131,188 shares; 2026Q2: 131,075 shares; 2026Q3: 178,036 shares 178,036$5.7M2.43%+46,961Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,403 shares 175,403$5.61M2.39%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 372,856 shares; 2026Q1: 372,856 shares; 2026Q2: 372,856 shares; 2026Q3: 372,856 shares 372,856$5.44M2.32%0Timeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$4.66M1.99%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 42,778 shares; 2026Q1: 52,655 shares; 2026Q2: 52,655 shares; 2026Q3: 52,655 shares 52,655$3.45M1.47%0Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 68,249 shares; 2026Q3: 69,549 shares 69,549$2.67M1.14%+1,300Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.99M0.85%newTimeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 111,455 shares 111,455$1.33M0.57%newTimeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 228,286 shares; 2026Q1: 184,063 shares; 2026Q2: 119,063 shares; 2026Q3: 119,063 shares 119,063$983K0.42%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BIOABIOAGE LABS INC100,732$2.47Mshares
ACETADICET BIO INC157,827$1.36Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-004969 base2026-11-13